Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Lasers in Surgery and Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/lsm.1900080312PMID 2969070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PHOTODYNAMIC THERAPY

  1993cited by this paper
• Porphyrin localization and treatment of tumors

  1985cited by this paper
• Photocytotoxicity in vivo of haematoporphyrin derivative components.

  1985cited by this paper
• Delayed phase of hematoporphyrin-induced phototoxicity: modulation by complement, leukocytes, and antihistamines.

  1985cited by this paper
• PORPHYRIN PHOTOSENSITIZATION AND CAROTENOID PROTECTION IN MICE; IN VITRO AND IN VIVO STUDIES

  1984cited by this paper
• Participation of mast cells and complement in the immediate phase of hematoporphyrin-induced phototoxicity.

  1984cited by this paper
• Mechanisms of photooxygenation.

  1984cited by this paper
• Tumor-localizing components of the porphyrin preparation hematoporphyrin derivative.

  1983cited by this paper
• Photosensitization by porphyrins and prevention of photosensitization by carotenoids.

  1982cited by this paper
• The main photosensitizing components of hematoporphyrin derivative.

  1982cited by this paper
• Variability in hematoporphyrin derivative preparations.

  1982cited by this paper
• Hematoporphyrin derivative in the detection and localization of radiographically occult lung cancer.

  1982cited by this paper
• Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue.

  1979cited by this paper
• Photoradiation therapy for the treatment of malignant tumors.

  1978cited by this paper
• Photoprotection in erythropoietic protoporphyria: mechanism of photoprotection by beta carotene.

  1977cited by this paper
• Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin.

  1977cited by this paper
• Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.

  1976cited by this paper
• Cutaneous changes in the porphyrias. A microscopic study.

  1973cited by this paper
• Hematoporphyrin‐Derivative Fluorescence in Malignant Neoplasms

  1968cited by this paper
• Hematoporphyrin-derivative fluorescence in malignant neoplasms.

  1968cited by this paper
• PROTECTIVE EFFECT OF BETA-CAROTENE LETHAL PHOTOSENSITIZATION BY HAEMATOPORPHYRIN.

  1964cited by this paper
• Protective Effect of β-Carotene against Lethal Photosensitization by Hæmatoporphyrin

  1964cited by this paper
• The use of a derivative of hematoporphyrin in tumor detection.

  1961cited by this paper
• The use of a derivative of hematoporhyrin in tumor detection.

  1961cited by this paper

• Graphene-Based Nanomaterials in Photodynamic Therapy: Synthesis Strategies, Functional Roles, and Clinical Translation for Tumor Treatment

  2025cites this paper
• Cutaneous photosensitivity of phototheranostic porphyrin–lipid nanoparticles

  2025influential citation
• Photodynamic Therapy and Cardiovascular Diseases

  2024cites this paper
• Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging

  2024cites this paper
• Photodynamic Therapy can Be Safely Performed with Talaporfin Sodium as A Day Treatment for Central-type Early-stage Lung Cancer.

  2022cites this paper
• Photodynamic therapy for atherosclerosis. The potential of Indocyanine Green.

  2020cites this paper
• Optical Characterization of an Intra-Arterial Light and Drug Delivery System for Photodynamic Therapy of Atherosclerotic Plaque

  2020cites this paper
• Development and Applications of Porphyrin-Phospholipid Liposomes

  2019influential citation
• Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation?

  2017cites this paper
• Metal Chelation Modulates Phototherapeutic Properties of Mitoxantrone-Loaded Porphyrin-Phospholipid Liposomes.

  2016cites this paper
• Intra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne®: Implication for Atherosclerotic Plaque Treatment

  2016cites this paper
• Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release.

  2016cites this paper
• Rapid Light-Triggered Drug Release in Liposomes Containing Small Amounts of Unsaturated and Porphyrin-Phospholipids.

  2016cites this paper
• Enhancing photodynamic therapy of refractory solid cancers : Combining second-generation photosensitizers with multi-targeted liposomal delivery

  2015cites this paper
• ZnO nanoparticles as drug delivery agent for photodynamic therapy

  2014cites this paper
• Hematoporphyrin encapsulated PLGA microbubble for contrast enhanced ultrasound imaging and sonodynamic therapy

  2012cites this paper
• Photodynamic Activity of Liposomal Photosensitizers via Energy Transfer from Antenna Molecules to [60]Fullerene.

  2010cites this paper
• Cytostatic and cytotoxic drugs

  2010cites this paper
• Photodynamische Therapie in der Dermatologie

  2010cites this paper
• Protection Afforded by Sunscreens Containing Inorganic Sunscreening Agents Against Blue Light Sensitivity Induced by Aminolevulinic Acid

  2008cites this paper
• Photodynamic therapy with mTHPBC for colorectal liver metastases

  2005cites this paper
• Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy

  2005cites this paper
• Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes.

  2004cites this paper
• Photodynamic effects of Radachlorin on cervical cancer cells.

  2004cites this paper
• Topical and light-based treatments for basal cell carcinoma.

  2003cites this paper
• DURATION OF SKIN PHOTOSENSITIVITY AND INCIDENCE OF PHOTOSENSITIVITY REACTIONS AFTER ADMINISTRATION OF VERTEPORFIN

  2002cites this paper
• Chapter 11 Systemic sensitization — non-oncologic indications in dermatology

  2001cites this paper
• Porphyrin self‐assembly as template for RNA?

  2001cites this paper
• 5-Aminolevulinic Acid–based Photochemical Internalization of the Immunotoxin MOC31-gelonin Generates Synergistic Cytotoxic Effects In Vitro¶

  2001cites this paper
• 5‐Aminolevulinic Acid–based Photochemical Internalization of the Immunotoxin MOC31‐gelonin Generates Synergistic Cytotoxic Effects In Vitro ¶

  2001cites this paper
• Skin-photosensitizing properties of Zn(II)-2(3), 9(10), 16(17), 23(24)-tetrakis-(4-oxy-N-methylpiperidinyl) phthalocyanine topically administered to mice.

  2000cites this paper
• A comparative study of normal and reverse phase high pressure liquid chromatography for analysis of porphyrins accumulated after 5-aminolaevulinic acid treatment of colon adenocarcinoma cells.

  2000cites this paper
• Photodynamic therapy in dermatology.

  2000cites this paper
• Endos485 977__985

  2000cites this paper
• Fluorescence Diagnosis in GI Endoscopy

  2000cites this paper
• CONTINUING MEDICAL EDUCATION Mucocutaneous reactions to chemotherapy

  1999cites this paper
• Mucocutaneous reactions to chemotherapy.

  1999cites this paper
• Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long‐term results

  1998cites this paper
• Photosensitization of skin‐derived cell lines by Dimegin [2,4‐di‐(α‐methoxyethyl)‐deuteroporphyrin IX] in vitro

  1998cites this paper
• Clinical study of fluorescence induced by small dose of hematoporphyrin for diagnosing tumor

  1998cites this paper
• 5‐Aminolevulinic acid‐based photodynamic therapy

  1997cites this paper
• Photodynamische Therapie epithelialer Präkanzerosen und Karzinome

  1997cites this paper
• Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.

  1997cites this paper
• 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.

  1997cites this paper
• Current status of photodynamic therapy in dermatology.

  1997cites this paper
• Dosedependent photodynamic effects of 9-acetoxy-2,7,12,17-tetrakis(\-methoxyethyl)-porphycene in vitro

  1997cites this paper
• Dose-dependent Photodynamic Effects of 9-A ceto xy-2,7,12,17-tet ra ki s-(p- m et h o xyet hy I)- porphycene In Vitro

  1997cites this paper
• Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy.

  1996cites this paper
• Topical photodynamic therapy in dermatology.

  1996cites this paper
• Intrauterine 5-Aminolevulinic Acid Induces Selective Endometrial Fluorescence in the Rhesus and Cynomolgus Monkey

  1996cites this paper
• 9-Acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localization.

  1996cites this paper
• Photodynamic therapy: a promising new modality for the treatment of cancer.

  1996influential citation
• δ-Aminolevulinic acid induced fluorescence in tumour-bearing mice

  1995cites this paper
• delta-Aminolevulinic acid induced fluorescence in tumour-bearing mice.

  1995cites this paper
• Photodynamic therapy of primary skin cancer: a review.

  1995cites this paper
• Detection of squamous neoplasia by fluorescence imaging comparing porfimer sodium fluorescence to tissue autofluorescence in the hamster cheek-pouch model.

  1995cites this paper
• Reprints Available Directly from the Publisher Photocopying Permitted by License Only Photodynamic Therapy of Lung Cancer with Bronchial Artery Infusion of Photofrin

  1995cites this paper
• PARTIAL PROTECTION OF PHOTODYNAMIC‐INDUCED SKIN REACTIONS IN MICE BY N‐ACETYLCYSTEINE: A PRECLINICAL STUDY

  1994cites this paper
• Cutaneous drug reactions

  1994cites this paper
• PENETRATION POTENCY OF TOPICAL APPLIED δ‐AMINOLEVULINIC ACID FOR PHOTODYNAMIC THERAPY OF BASAL CELL CARCINOMA *

  1994cites this paper
• Adjuvant intraoperative photodynamic therapy for colorectal carcinoma: a clinical study.

  1994cites this paper
• Photodynamic Therapy for Cancers: A Clinical Trial of Porfimer Sodium in Japan

  1993cites this paper
• [Photodynamic therapy of skin tumors].

  1993cites this paper
• Transadventitial localisation of atheromatous plaques by fluorescence emission spectrum analysis of mono-L-aspartyl chlorin e6.

  1993cites this paper
• Photodynamic therapy with Photofrin II by bronchial artery infusion

  1993cites this paper
• Chromatographic analysis of asymmetric sulphophthalocyanines using a diode-array detector

  1993cites this paper
• Combination of Chemotherapy and Photodynamic Therapy of Human Gastrointestinal Tumor Xenografts in Nude Mice

  1992cites this paper
• Lasers in the treatment of skin cancer.

  1992cites this paper
• Detection of squamous cell cancer and pre-cancerous lesions by imaging of tissue autofluorescence in the hamster cheek pouch model.

  1992cites this paper
• Photodynamische Therapie humaner Kolonkarzinome: Substanzdosis- und Energiedichteabhängigkeit im thymusaplastischen Nacktmausmodell

  1992cites this paper
• Clinical effects of photodynamic therapy on recurrent laryngeal papillomas.

  1992cites this paper
• Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.

  1991cites this paper
• Argon laser therapy for perianal Bowen's disease: A case report

  1991cites this paper
• Dermatologic laser surgery.

  1990cites this paper
• Preferential uptake of a water-soluble phthalocyanine by atherosclerotic plaques in rabbits.

  1990cites this paper
• Detection of lung cancer by ratio fluorometry with and without Photofrin II

  1990cites this paper
• Chapter 10 – DYE LASERS IN MEDICINE

  1990cites this paper
• References

  1990cites this paper
• Dihematoporphyrin Ether‐Induced photosensitivity in laryngeal papilloma patients

  1990cites this paper
• Detection of early lung cancer using low dose Photofrin II.

  1990cites this paper
• Cutaneous phototoxic occurrences in patients receiving Photofrin®

  1990cites this paper
• Squamous cell carcinoma of the lower lip involving a large cutaneous surface. Photodynamic therapy as an alternative therapy.

  1990cites this paper
• Response of black and white guinea pig skin to photodynamic treatment using 514-nm light and dihematoporphyrin ether.

  1990cites this paper
• Gastrointestinal laser endoscopy--future horizons.

  1990cites this paper
• Protection of murine foot tissue and transplantable tumor against Photofrin-II-mediated photodynamic sensitization with WR-2721.

  1989cites this paper
• Glasnost and Perestroika--a challenge for modern medicine.

  1989cites this paper
• Photodynamic-Therapy By TPPS Topical Application And Dye-Laser In Basal Cell Carcinoma

  1989cites this paper
• THE TIME COURSE OF CUTANEOUS PORPHYRIN PHOTOSENSITIZATION IN THE MURINE EAR

  1989cites this paper
• Photosensitized patients and operating lights

  1989cites this paper
• Localization of hematoporphyrin. Derivative to human colorectal cancer

  1989cites this paper